Cargando…
Long-term follow-up of cumulative incidence of hepatocellular carcinoma in hepatitis B virus patients without antiviral therapy
BACKGROUND: China has a high prevalence of hepatitis B virus (HBV), but most chronic hepatitis B (CHB) patients do not receive standardized antiviral therapy. There are few relevant reports addressing the outcomes of the large number of CHB patients who do not receive antiviral therapy. AIM: To obse...
Autores principales: | Jiang, Xiao-Yan, Huang, Bing, Huang, Dan-Ping, Wei, Chun-Shan, Zhong, Wei-Chao, Peng, De-Ti, Huang, Fu-Rong, Tong, Guang-Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985729/ https://www.ncbi.nlm.nih.gov/pubmed/33776376 http://dx.doi.org/10.3748/wjg.v27.i11.1101 |
Ejemplares similares
-
Efficacy of a Chinese herbal formula on hepatitis B e antigen-positive chronic hepatitis B patients
por: Xing, Yu-Feng, et al.
Publicado: (2020) -
Trial watch: immunotherapeutic strategies on the horizon for hepatocellular carcinoma
por: Koh, Benjamin, et al.
Publicado: (2023) -
Transarterial chemoembolization with hepatic arterial infusion chemotherapy plus S-1 for hepatocellular carcinoma
por: Guo, Jian-Hai, et al.
Publicado: (2020) -
Effect of vitamin D supplementation in patients with chronic hepatitis C after direct-acting antiviral treatment: a randomized, double-blind, placebo-controlled trial
por: Sriphoosanaphan, Supachaya, et al.
Publicado: (2021) -
Antiviral therapy for hepatitis B virus-related hepatocellular carcinoma after radical hepatectomy
por: Ke, Yang, et al.
Publicado: (2013)